218 results on '"Asahina, Akihiko"'
Search Results
2. Region-specific activation in the accumbens nucleus by itch with modified scratch efficacy in mice – a model-free multivariate analysis
3. Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL
4. A case of leukemia cutis showing annular erythema during the course of Philadelphia chromosome‐positive acute B‐lymphoblastic leukemia
5. A case of varicella due to primary varicella zoster virus infection followed by respiratory disease on the background of an immunocompromised condition
6. A cross‐sectional questionnaire survey involving physicians for the clarification of the diagnosis and current status of therapeutic intervention of psoriatic arthritis in Japan
7. Number of itchy sites is important in evaluation for atopic dermatitis
8. Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange
9. A case of postoperative pyoderma gangrenosum on penis caused by patient himself
10. Relationships between severities of dermatological, neurological, and bone manifestations in neurofibromatosis type 1
11. Monitoring Sleep and Scratch Improves Quality of Life in Patients with Atopic Dermatitis
12. Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study
13. A Case of Multiple Acquired Depressed Smooth Muscle Hamartoma
14. A Case of Leukemia Cutis Showing Annular Erythema during the Course of Philadelphia Chromosome-Positive Acute B-lymphoblastic Leukemia
15. A Case of Varicella due to Primary Varicella Zoster Virus Infection Followed by Cytomegalovirus Reactivation on the Background of an Immunocompromised Condition
16. A case of systemic amyloidosis showing papular/nodular lesions due to Waldenström's macroglobulinemia
17. Bimekizumab Efficacy and Safety in Japanese Patients with Plaque Psoriasis in BE VIVID: A Phase 3, Ustekinumab and Placebo-Controlled Study
18. Light Chain Amyloidosis due to Waldenström’s Macroglobulinemia Showing Papular/Nodular Lesions
19. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)
20. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)
21. Summary of the current status of clinically diagnosed cases of Schnitzler syndrome in Japan
22. Abnormal peripheral blood cell counts in neurofibromatosis type 1
23. Generation of induced pluripotent stem cell ( iPSC ) from NY‐ESO‐I ‐specific cytotoxic T cells isolated from the melanoma patient with minor HLAs : The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology
24. Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: Chest CT imaging for screening purposes
25. 32937 Bimekizumab treatment response is maintained up to 3 years in patients with psoriatic arthritis: Responder analyses from BE ACTIVE, a phase 2b dose-ranging study, and its open-label extension
26. Abnormal Peripheral Blood Cell Counts in Neurofibromatosis Type 1
27. Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole‐related actinic keratosis
28. Abnormal Peripheral Blood Cell Counts in Neurofibromatosis Type 1
29. Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE
30. A Case of Solitary Angiokeratoma Dermoscopically Mimicking Black Palm --A Dermoscopic Pitfall--
31. Multiple Phenotypic Conversion in Malignant Melanoma: Obtainment of Granulocyte Colony-Stimulating Factor-Producing Ability during the Intermission of Nivolumab Therapy
32. Improved renal function in neurofibromatosis type 1 patients
33. Case of follicular mucinosis showing brownish yellow and red dots via dermoscopy
34. Case of hypothyroidism‐diagnostic unclassified cutaneous mucinosis showing a plaque on the flank region
35. Successful treatment with dacarbazine against a parathyroid hormone‐related protein‐producing melanoma causing hypercalcemia after immune checkpoint inhibitor failure
36. Precritical abnormalities in routine blood parameters in necrotizing fasciitis
37. Low Body Weight as a Risk Factor for Apalutamide-related Cutaneous Adverse Events
38. Case of Follicular Mucinosis Showing Brownish Yellow and Red Dots via Dermoscopy
39. Characteristics of Rosacea and Similar Diseases in Patients Wearing Face Masks
40. Relationship between iodine‐enhanced dual energy‐computed tomographic findings and ultrasonographic findings for psoriatic arthritis
41. Common Features and Intra-Species Variation of Cutibacterium modestum Strains, and Emended Description of the Species
42. Bimekizumab response maintenance through two years of treatment in patients with moderate to severe plaque psoriasis who responded after 16 weeks: Interim results from the BE BRIGHT open-label extension trial
43. A case of desmoplastic trichoepithelioma accompanied by pseudolymphoma
44. Mosaic Neurofibromatosis 1
45. Unravelling the eco-specificity and pathophysiological properties of Cutibacterium species in the light of recent taxonomic changes
46. 25995 5-year efficacy of tildrakizumab 100 and 200 mg by PASI 50/75/90/100 and PGA in reSURFACE 1
47. 27368 Psoriasis Symptoms and Impacts Measure (P-SIM) responses from the BE VIVID bimekizumab in moderate to severe plaque psoriasis phase 3 trial
48. 25997 Safety of tildrakizumab 100 mg and 200 mg through 5 years of exposure in reSURFACE 1
49. Case of carbon‐ion radiation recall mucositis associated with anti‐programmed cell death 1 treatment for paranasal sinuses melanoma
50. Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long‐term therapy for mild‐to‐moderate plaque psoriasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.